Highline Wellness
High quality, direct-to-consumer CBD supplements for everyday problems
Overview
$1,710,300 - Total
Rolling Commitments ($USD)
04/30/2023
$486
48
2018
Healthcare & Pharmaceuticals
HealthTech
B2C
High
Low
Summary Profit and Loss Statement
FY 2021 | FY 2020 | |
---|---|---|
Revenue |
$4,533,245 |
$3,877,824 |
COGS |
$1,845,872 |
$1,352,657 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-2,538,612 |
$-411,374 |
Summary Balance Sheet
FY 2021 | FY 2020 | |
---|---|---|
Cash |
$375,344 |
$319,189 |
Accounts Receivable |
$6,177 |
$29,844 |
Total Assets |
$1,469,530 |
$1,406,975 |
Short-Term Debt |
$1,634,641 |
$586,690 |
Long-Term Debt |
$141,228 |
$176,733 |
Total Liabilities |
$1,775,869 |
$763,423 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual